Global Longlife Hospital and Research Limited

About

Global Longlife Hospital and Research Limited, a multi-speciality tertiary care hospital, provides medical and surgical specialities services in India. It offers medical services, such as oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anaesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, GI medicine, gynecology, infectious disease, nephrology, and neurology; and surgical services, including CVTS, joint replacement orthopaedics, spine surgery, general surgery, onco surgery, GI surgery, neurosurgery, ENT, plastic surgery, trauma centre, urology, laparoscopic surgery, gynaecology, dental surgery, and vascular surgery. It also provides radiology services comprising mammography, CT scan, X-ray, ultrasound, endoscopy, and sonography; pathology services, such as microbiology, biochemistry, clinical pathology, cyto pathology, haematology, and serology; and other services that include dialysis, pharmacy, ambulance, dietary, and physiotherapy services. Global Longlife Hospital and Research Limited was incorporated in 2012 and is based in Ahmedabad, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in — check back soon.

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Sales	0.00	0.31	13.46	23.38	32.44	32.70	33.32	33.44
Expenses	1.00	4.45	13.68	19.30	24.14	27.26	29.88	26.61
Operating Profit	-1.00	-4.14	-0.22	4.08	8.30	5.44	3.44	6.83
OPM %	—	-1,335.48	-1.63	17.45	25.59	16.64	10.32	20.42
Other Income	0.01	5.02	0.00	0.24	0.17	0.06	0.03	0.08
Interest	0.00	0.30	0.80	0.45	1.62	2.44	2.41	2.07
Depreciation	0.00	0.48	1.25	1.17	1.14	1.31	2.13	2.15
Profit before tax	-0.99	0.10	-2.27	2.70	5.71	1.75	-1.07	2.69
Tax %	73.74	-100.00	-3.52	32.59	37.30	-16.57	-18.69	49.07
Net Profit	-1.72	0.20	-2.19	1.83	3.57	2.05	-0.86	1.36
EPS in Rs	-1.64	0.19	-2.09	1.74	5.10	2.93	-1.23	1.94
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Equity Capital	10.50	10.50	10.50	10.50	7.00	7.00	7.00	7.00
Reserves	13.25	16.29	15.43	53.79	9.96	6.68	4.49	5.35
Borrowings	0.00	0.00	12.74	9.29	8.69	17.04	23.51	27.18
Other Liabilities	0.01	0.06	3.07	2.36	8.33	6.06	6.92	3.77
Total Liabilities	23.76	26.85	41.74	75.94	33.98	36.78	41.92	43.30
Fixed Assets	0.00	0.00	17.27	16.52	16.71	17.46	18.72	20.17
CWIP	0.00	0.00	0.00	1.03	0.00	0.00	0.00	0.00
Investments	0.00	0.03	0.03	0.10	0.10	0.47	0.10	0.10
Other Assets	23.76	26.82	24.44	58.29	17.17	18.85	23.10	23.03
Total Assets	23.76	26.85	41.74	75.94	33.98	36.78	41.92	43.30

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash from Operating Activity	-4.51	12.32	-5.07	-40.42	9.42	6.88	3.90	5.40
Cash from Investing Activity	0.04	21.80	-0.82	-1.90	0.01	0.02	-0.04	-0.33
Cash from Financing Activity	0.00	-13.01	2.67	45.70	-9.66	-7.22	-3.05	-4.77
Net Cash Flow	-4.47	21.11	-3.22	3.38	-0.22	-0.33	0.81	0.31
Free Cash Flow	-4.51	33.42	-6.10	-42.42	8.96	6.84	3.79	5.00
CFO/OP %	401.00	-304.00	2,259.00	-960.00	105.00	126.00	113.00	79.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Debtor Days	—	376.77	52.88	151.43	100.25	87.51	68.68	94.85
Inventory Days	—	0.00	131.64	69.12	88.98	34.46	157.97	169.49
Days Payable	—	—	765.90	110.43	432.74	138.68	391.69	229.91
Cash Conversion Cycle	—	376.77	-581.38	110.13	-243.52	-16.71	-165.03	34.44
Working Capital Days	—	1,283.39	-238.36	344.86	-29.70	7.14	12.16	19.21
ROCE %	-3.92	-13.69	-2.51	6.35	26.22	12.75	3.81	—

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	22.88	22.88	35.44	55.10	54.90	54.29	54.29	54.29	54.29	54.29	54.29	54.29
Public	77.12	77.11	64.56	44.91	45.10	45.70	45.72	45.73	45.72	45.71	45.71	45.72
No. of Shareholders	1,133	1,149	985	915	917	938	989	974	1,010	947	935	880